Current Report · Items 2.02, 9.01 · 8-K
Starling Oncology, Inc.
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On August 6, 2026, Starling Oncology, Inc. (the "Company") issued a press release announcing its financial results for the three months ended June 30, 2026 and certain other financial information. A copy of the press release is furnished hereto as Exhibit 99.1, which is incorporated by reference herein.…
Filed Aug 6, 2026Accepted Aug 6, 2026, 4:32 PM EDTCIK 1799191Accession 0001079973-26-001006
Company context
Current securities
Historical securities (5)
Registered securities in this filing
STARLING ONCOLOGY, INC. · 8-K · Filed 2026-08-06
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common stock, par value $0.0001
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Filing context
Context: From2026-08-062026-08-06_custom_CommonStockParValue0.0001Member
Dimensions: us-gaap:StatementClassOfStockAxis
Redeemable warrants, each whole warrant exercisable for one share of Common stock, each at an exercise price of $11.50 per share
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Historical · closed Aug 3, 2026
Filing context
Context: From2026-08-062026-08-06_custom_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockEachAtExercisePriceOf11.50PerShareMember
Dimensions: us-gaap:StatementClassOfStockAxis
Accession 000107997326001006 · 2 registered-security cover members
Read the exact SEC filing ↗Disclosure sections
Items 2.02, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition
On August 6, 2026, Starling Oncology,
Inc. (the "Company") issued a press release announcing its financial results for the three months ended June 30, 2026
and certain other financial information. A copy of the press release is furnished hereto as Exhibit 99.1, which is incorporated by reference
herein.
The information contained in Item 2.02 of
this Current Report and Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section.